Cargando…
Interleukin-6 inhibition in the treatment of autoinflammatory diseases
Autoinflammatory diseases are characterized by abnormalities that prevent innate immune cells from producing autoantibodies. While interleukin (IL)-6 is not directly associated with inflammasomes, like IL-1β or IL-18, it plays an important role in the pathogenesis of autoinflammatory diseases. Studi...
Autores principales: | Koga, Tomohiro, Kawakami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360993/ https://www.ncbi.nlm.nih.gov/pubmed/35958618 http://dx.doi.org/10.3389/fimmu.2022.956795 |
Ejemplares similares
-
Autoinflammatory disease: clinical perspectives and therapeutic strategies
por: Kawakami, Atsushi, et al.
Publicado: (2022) -
Correction: Autoinflammatory disease: clinical perspectives and therapeutic strategies
por: Kawakami, Atsushi, et al.
Publicado: (2022) -
Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases
por: Shimizu, Masaki, et al.
Publicado: (2022) -
An autoinflammatory neurological disease due to interleukin 6 hypersecretion
por: Salsano, Ettore, et al.
Publicado: (2013) -
Modulation of Autoimmune and Autoinflammatory Diseases by Gasdermins
por: Liang, Fang, et al.
Publicado: (2022)